UnitedHealth Group raises its dividend rapidly, but unexpectedly high medical expenses are pressuring profits this year.

UnitedHealth Group is preparing to report its Q2 2025 earnings, with analysts predicting a drop in earnings per share (EPS) to $5.08. The company’s stock has underperformed significantly over the last ...

Health-care companies rose as deal activity offset more health-insurance controversy. Merck struck a roughly $10 billion deal to buy Verona Pharma, bolstering its lineup with the chronic obstructive ...

UnitedHealth Group's recent office mandate has employees returning more days per week, but the company's recent real estate ...

The Dow Jones Industrial Average was erasing most of its morning gains ahead of midday trading on Wednesday. Here's a look at what is putting pressure on the blue-chip index: UnitedHealth Group Inc.'s ...

UnitedHealth Group Inc. promoted a new leader for the company’s Medicaid insurance segment, filling a role that was vacant ...

The Department of Justice is interviewing former employees as part of its criminal Medicare fraud probe into UnitedHealth, according to ...

Merry Kogut filed a derivative suit on June 14, alleging that UnitedHealth's leadership failed to disclose a Department of ...

UnitedHealth Group (NYSE: UNH) has spent a significant amount of time in the sick bay for the first half of 2025, but it’s ...

UnitedHealth Group stock declined on Wednesday following a report from the Wall Street Journal that ex-employees and medical ...

The revised price target follows statements made by UnitedHealth’s reinstated CEO during the company’s annual meeting on June ...

Investigators from the U.S. Department of Justice are questioning former employees of UnitedHealth Group as part of a probe ...